Skip to main content
PROTEOME SCIENCES PLC logo

PROTEOME SCIENCES PLC — Investor Relations & Filings

Ticker · PRM ISIN · GB0003104196 LEI · 213800Q62ICXANKU2986 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2021-06-08 Director's Dealing
Country GB United Kingdom
Listing IL PRM

About PROTEOME SCIENCES PLC

https://www.proteomics.com/

Proteome Sciences PLC is a specialized Contract Research Organization (CRO) focused on applied proteomics and peptidomics. The company provides comprehensive mass spectrometry-based analytical services to support drug discovery, development, and biomarker identification for precision medicine. Its services cover the full workflow from sample preparation and proteome characterization to bioinformatics data interpretation and reporting, handling diverse biological samples. A key offering is its proprietary TMT® and TMTpro® isobaric tags, which the company invented, developed, and exclusively manufactures for multiplexed protein quantification. These reagents are distributed globally to the mass spectrometry community. The company serves the biopharmaceutical sector, operating under ISO 9001:2015 and Good Clinical Laboratory Practice (GCLP) standards for its targeted assays.

Recent filings

Filing Released Lang Actions
Grant of Options and PDMR/director shareholdings
Director's Dealing Classification · 1% confidence The document is an RNS announcement dated 08 June 2021. The primary content details the 'Grant of Options and PDMR/director shareholdings' for three directors (Mariola Soehngen, Ian Pike, Richard Dennis). It explicitly states that the notification is made in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation and the UK Market Abuse Regulation, which mandates disclosure of transactions by Persons Discharging Managerial Responsibilities (PDMRs). This type of filing, reporting personal share transactions by directors/executives, directly corresponds to the 'Director's Dealing' category.
2021-06-08 English
Issuance of key TMT Patent
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 2049Z' and is dated May 19, 2021. It contains language typical of a regulatory news service announcement, such as 'Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulations. With the publication of this announcement, this information is now considered to be in the public domain.' The content announces a patent issuance and the launch of new services, which is a material corporate event announcement. Since it is distributed via RNS (the news service of the London Stock Exchange) and is a general regulatory announcement that doesn't fit specific categories like ER, DIV, or CAP, the most appropriate classification is Regulatory Filings (RNS). The document length (6149 chars) is substantial enough that it is the announcement itself, not just a pointer to a report.
2021-05-19 English
Change of Registered Office
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content announces a 'Change of Registered Office' for Proteome Sciences plc. This is a routine, non-financial, mandatory disclosure to the market regulator (FCA/LSE). Since it is a general regulatory announcement that doesn't fit into specific categories like Director's Dealing (DIRS), Dividend (DIV), or Management Change (MANG), the most appropriate classification is the general Regulatory Filings category (RNS). The document length (2650 chars) is short, but the content is the announcement itself, not an announcement *about* a report, so RPA is less suitable than RNS for this type of administrative update.
2021-05-18 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document text is very short (1917 characters) and contains the header 'RNS Number : 4360Y' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a brief announcement titled 'Price Monitoring Extension' regarding an auction call extension, which is a specific operational update related to trading mechanics. This type of short, specific regulatory announcement that doesn't fit into the major financial reporting categories (like 10-K, ER, IR) is best classified as a general Regulatory Filing (RNS), as it is distributed via the RNS system.
2021-05-12 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1934 characters) and its primary content is an announcement regarding a 'Second Price Monitoring Extension' for a security, referencing the 'RNS Number' and stating that this information is provided by 'RNS, the news service of the London Stock Exchange.' This structure—a brief notification about a market event or regulatory process, distributed via the RNS system—fits the definition of a general regulatory announcement that doesn't align with specific financial reports (like 10-K, ER, IR) or corporate actions (like DIV, CAP). Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for miscellaneous regulatory announcements.
2021-05-07 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number : 9833X' and contains information about a 'Price Monitoring Extension' related to trading on the London Stock Exchange. It concludes by stating, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure and content strongly indicate a general regulatory announcement disseminated via the RNS system, which aligns with the 'Regulatory Filings' category (RNS) as a general regulatory announcement/miscellaneous filing.
2021-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.